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Introduction 
The use of alcohol and drugs is a signifi-
cant public health problem in the United
States. The Substance Abuse and Mental
Health Services Administration (SAMH-
SA) estimated that in 2015, 13.1 million
American adults had an alcohol use disor-
der, 5.1 million had an illicit substance use
disorder, and an additional 2.7 million
had both disorders [1]. These estimates do
not include the millions of people across
the country who use alcohol or drugs at
lower, but still problematic levels [1, 2].
The economic impact attributable to sub-
stance use is staggering. Estimates from
2007 indicate that the consequences aris-
ing from alcohol and illicit drug use have
cost the nation $223.5 and $193 billion
respectively. Much of the expense stems
from lost productivity in the labor force,
treatment for substance use disorders and
their associated health consequences, and
alcohol- and drug-related criminal justice
activities [3, 4]. Loss of life is a particularly
significant outcome tied to substance use
that cannot be measured in dollars. The
age-adjusted rate of drug- and alcohol-
related deaths has increased by 88%, from
14.0 deaths per 100,000 in 1999 to 26.3
deaths per 100,000 in 2015 [5]. To better
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SUMMARY
•    The purpose of this brief is to review trends in alcohol and other drug use as well as treatment availabil-
ity in Indiana across the urban/rural continuum.
•    We used the Purdue University Center for Rural Development’s criter ia to define counties as urban,
rural/mixed, or rural.
•    All analyses were based on publicly available data sources, including information from the U.S. Census
Bureau, Indiana’s Treatment Episode Data System, the National Survey of Substance Abuse Treatment
Services, the National Provider Identifier dataset, and the Buprenorphine Provider database. 
•    The most striking differences of drug use by urban/rural category were found for methamphetamine
and cocaine, with methamphetamine use being more prevalent in rural areas and cocaine use more
widespread in urban counties.
•    Injection drug use (IDU) in Indiana’s substance abuse treatment population increased significantly from
2010 to 2016 across all urban/rural categories. In 2016, the IDU rate was lowest among urban dwellers,
higher among rural Hoosiers, and highest among those living in rural/mixed areas.
•    Indiana, like many other states in the nation, is lacking in substance abuse treatment services and rural
areas are particularly underserved. Of the 235 agencies offering care, 129 agencies (54.9%) are located
in urban counties, 64 agencies (27.2%) are in rural/mixed counties, and 43 (17.8%) are in rural counties.
Furthermore, 11 rural counties have no substance abuse treatment agencies whatsoever. 
•    Rural residents may encounter additional barriers to receiving substance abuse treatment, including
stigma, fear that they may know their treatment providers, a lack of access to specialized services, infe-
rior quality of care, and having to pay more for treatment.
•    There are currently 14 opioid treatment programs (OTPs) operating in Indiana; 13 are overseen by the
Division of Mental Health and Addiction and one is administered by the Veteran’s Administration. Of
these, 10 OTPs are in urban areas and four are in rural/mixed areas; no OTPs are located in rural coun-
ties.
•    Based on the findings, we recommend the following
o Expand substance abuse treatment services, especially in rural and rural/mixed areas.
o Increase availability of medication-assisted treatment, especially in rural/mixed areas.
o Increase distribution and use of naloxone, especially in rural and rural/mixed areas.
o Enhance Indiana’s capacity to provide internet-based services to Hoosiers struggling with metham-
phetamine (and other drug) use in more remote areas of the state.
o Provide training and mentoring to healthcare professionals on how to identify substance abuse in
patients and provide treatment.
o Incentivize treatment professionals to work in more rural areas.
address alcohol and other drug use, poli-
cymakers need to know what the most
commonly used substances are, where in
the state these substances are being
used, and who is using them. The pur-
pose of this report is to describe varia-
tions in drug use and related conse-
quences, as well as the availability of
treatment resources in Indiana across the
urban-rural continuum. Our goal is to
inform policymakers and planners, prevention and treatment profes-
sionals, as well as the general public about the status of substance use,
abuse, and treatment opportunities available across differing geograph-
ic areas of the state. 
Background
Many in the U.S. hold a longstanding belief that the majority of the
economic and social consequences tied to substance use are generated
within the country’s more densely populated, urban areas—areas
which are perceived as having higher rates of unemployment, crime,
poverty, and familial instability [6]. Since at least the 1980s, rural
America has experienced significant economic hardships, job loss, out-
migration of young adults, a breakdown of traditional familial and
community networks, and greater encroachment from urban areas [7].
The increase of these factors accompanies a concomitant rise in the
level of alcohol and marijuana use among high school students living in
rural areas; by 1992, these had reached levels similar to that of urban
youth [6]. More recent studies examining differences in the overall
prevalence of illicit drug use among urban and rural environments have
produced inconsistent results. Some concluded that illicit drug use is
higher among individuals in urban areas [8, 9], some that it is higher
among rural individuals [10, 11], and at least one found that the level of
illicit drug use is nearly the same across urban and rural areas [12]. The
discrepancies among these and other studies assessing substance use
across urban and rural areas are likely due to a number of variables,
including how authors define what constitutes an urban or rural area,
the use of respondent groups that are often drawn from very select
populations (e.g., probationers living in specific rural or urban areas,
pregnant women entering substance abuse treatment), or the use of
data drawn from individuals within a single state or part of a state. As
findings across studies are somewhat discrepant and may be state-spe-
cific, this report will focus specifically on patterns of urban and rural
drug use as they exist within Indiana; however, we will reference
national-level trends when data are available.
Defining Urban and Rural
One of the main pitfalls of research exploring urban-rural differences is
the lack of consensus among researchers, government agencies, and
others of what exactly constitutes an urban or rural area. The U.S. gov-
ernment uses over two dozen definitions of the construct, employing
specific definitions based upon the particular situation of interest.
Despite this variety, the categorization scheme used most often when
comparing substance use across urban and rural communities is the U.
S. Department of Agriculture’s rural-urban continuum codes (RUCC).
RUCC are based on the population size within a county, categorizing it
on a nine-point scale from metro (county population of 1 million or
more) to completely rural (county population of less than 2,500).
While the RUCC codes are helpful in highlighting fine-grained distinc-
tions among large population areas, their use at the state level is limited
due to insufficient residents living in the more extreme rural categories. 
For this report, we utilized a three-level categorization of the urban-
rural continuum created by the Purdue University Center for Rural
Development. Similar to the RUCC, the designation of urban or rural is
determined by population size, placing counties into one of three cate-
gories: urban, rural/mixed, or rural. This scheme is tailored specifically
to Indiana and incorporates the concept of “county identity;” i.e., how a
county’s residents define their county’s urban or rural status [13]. 
Table 1 describes the criteria used to define the three population cate-
gories proposed by the Purdue University Center for Rural
Development [13]. For additional details, see Appendix 1.
Data Sources 
For the analyses presented in this report, we used data from a variety of
publicly available data sources, including information from the U.S.
Census Bureau, Indiana’s Treatment Episode Data System, the
National Survey of Substance Abuse Treatment Services, the National
Provider Identifier dataset, and the Buprenorphine Provider database.
For details on these data sources, see Appendix 2.
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Table 1. Criteria Used for Classifying Indiana Counties 
Source: Purdue University Center for Rural Development
Criteria Rural Rural/Mixed Urban
Population Less than 40,000 40,000 to 100,000 Over 100,000
Density (people per sq. mi.) Less than 100 100 to 200 Over 200
Population of largest city Less than 10,000 10,000 to 30,000 Over 30,000
Identity Rural Rural with larger town(s) Urban/suburban
Number of counties 42 33 17
3Demographic Composition
by Urban/Rural Category
The demographic composition varied
among the urban/rural categories for
some characteristics. Population-dense
areas were racially more diverse. Though
the median income was higher in urban
areas, the percentage of people living in
poverty was also greater compared to
more rural regions. Residents in rural
locations were more likely to own their
homes. For details on demographic char-
acteristics, see Table 2. 
Demographic Composition
of Indiana’s Substance
Abuse Treatment
Population
Across all three urban/rural categories,
males accounted for a larger percentage of
admissions than females; whites were
more prominent than other racial groups,
especially in more rural counties; and
young adults ages 25 to 34 represented
most of the treatment admissions. For
additional details, see Table 3. 
Substance Use in Indiana’s
Treatment Population
For the following analyses, we utilized
information from Indiana’s Treatment
Episode Data Set (TEDS), computing sub-
stance use rates among the adult treatment
population. For this, we divided the num-
ber of treatment admissions for consumers
18 years of age or older who reported the
use of a specific drug (alcohol, marijuana,
cocaine, methamphetamine, heroin, pre-
scription opioids, or other prescription
drugs) by the adult county population, and
multiplied the result by 1,000. Differences
between rates were determined by calcu-
lating 95% confidence intervals for the
ratio between rates. Significant differences
Table 2. Demographic Characteristics by Urban/Rural Categories
Source: U.S. Census Bureau – Community Fact Finder (CFF)
Urban Rural/Mixed Rural
(%) (%) (%)
Gender
Male 49.0% 49.4% 50.0%
Female 51.0% 50.6% 50.0%
Race/Ethnicity
Non-Hispanic White 73.6% 88.2% 95.2%
Non-Hispanic Black 13.5% 3.6% 0.9%
Non-Hispanic Other Race 4.9% 3.0% 1.6%
Hispanic (All Races) 8.0% 4.6% 2.3%
Age
Less than 18 24.3% 24.0% 23.6%
18 to 24 11.0% 9.2% 8.3%
25 to 44 26.6% 24.0% 23.2%
45 to 64 25.4% 27.4% 28.5%
65 and Older 12.7% 15.3% 16.3%
Education
High School or More 88.2% 87.4% 85.7%
Housing
% of population residing in owner-occupied housing 67.5% 75.0% 78.6%
Poverty & Income
% of Individuals ≥18 in poverty 16.7% 14.3% 13.2%
% of Households in poverty 11.9% 10.4% 9.4%
% of Households with children <18 in poverty 19.4% 17.7% 15.7%
Avg. Median Income $51,049.00 $48,616.00 $47,230.00
Employment & Industry
Avg. Unemployment Rate 8.6 8.6 8.2
% in manual labor/blue-color-type employment 29.4% 37.5% 42.9%
Table 3. Demographic Composition of Indiana’s Adult Substance Abuse Treatment Population, 2016 
Source: Treatment Episode Data Set (TEDS)
Urban Rural/Mixed Rural
Gender (%) (%) (%)
Male 10,428 (59.4%) 5,768 (60.1%) 2,853 (60.0%)
Female 7,114 (40.6%) 3,832 (39.9%) 1,900 (40.0%)
Race
White, Non-Hispanic 11,912 (67.9%) 8,272 (86.2%) 4,286 (90.2%)
Black, Non-Hispanic 3,193 (18.2%) 258 (2.7%) 50 (1.1%)
Other, Non-Hispanic 1,109 (6.3%) 532 (5.5%) 233 (4.9%)
Hispanic – All Races 1,328 (7.6%) 538 (5.6%) 184 (3.9%)
Age
18-24 3,179 (18.1%) 2,028 (21.1%) 1,071 (22.5%)
25-34 6,418 (36.6%) 3,706 (38.6%) 1,815 (38.2%)
35-44 3,914 (22.3%) 2,177 (22.7%) 1,044 (22.0%)
45-54 2,641 (15.1%) 1,177 (12.3%) 573 (12.1%)
55 and Older 1,390 (7.9%) 512 (5.3%) 250 (5.3%)
Admission History
0 or 1 prior admission 16,526 (94.2%) 8,829 (92.0%) 4,592 (96.6%)
2 or more prior admissions 1,016 (5.8%) 771 (8.0%) 161 (3.4%)
4among urban-rural categories were deter-
mined using standard difference of propor-
tions tests. 
Estimates of overall substance use were
based on the annual number of adult
TEDS admissions. For the state, the rate of
overall substance misuse increased slightly
from 2010 to 2011 and has remained rela-
tively stable since that time. Substance
misuse has been gradually increasing in
rural/mixed counties and increasing but
then somewhat decreasing in rural coun-
ties. In urban areas, substance misuse has
slightly decreased and is below the rates
for the more rural regions (see Figure 1). 
Alcohol Use in Indiana’s
Treatment Population 
Estimates based on TEDS data show that
the rate of problematic alcohol use has
decreased in Indiana since 2010 to a low of
3.19 per 1,000 population. Urban counties
have experienced a steady decline in their
rate of problematic use, while rural/mixed
and rural counties have seen an increase in
use followed by somewhat of a decrease.
Compared to 2010, the rate of problematic
alcohol consumption was significantly
lower in urban and rural counties in 2016;
rates in rural/mixed areas were statistically
similar in 2010 and 2016 (see Figure 2). 
Figure 1. Rate of Substance Misuse in Indiana’s Treatment Population, by Urban-Rural Categories 
Source: Treatment Episode Data Set (TEDS)
Figure 2. Rate of Alcohol Use in Indiana’s Treatment Population, by Urban-Rural Categories 
Source: Treatment Episode Data Set (TEDS)
5Marijuana Use in Indiana’s
Treatment Population
At the state level, marijuana use has
remained relatively stable. Across the pop-
ulation density categories, marijuana use
started out at higher rates in urban coun-
ties compared to both rural/mixed and
rural counties. Since 2010, use has
decreased in urban areas, increased in
rural/mixed areas, and increased slightly
then stabilized in rural areas (see Figure 3).
Cocaine Use in Indiana’s
Treatment Population
Cocaine use has decreased throughout
Indiana since 2010. Across all years
reviewed, the rate of cocaine use has been
greatest in urban counties, followed by
rural/mixed, and then rural areas. Urban
counties experienced a significant drop in
cocaine use from 2010 to 2016 (see Figure 4). 
Figure 3. Rate of Marijuana Use in Indiana’s Treatment Population, by Urban-Rural Categories
Source: Treatment Episode Data Set (TEDS)
Figure 4. Rate of Cocaine Use in Indiana’s Treatment Population, by Urban-Rural Categories 
Source: Treatment Episode Data Set (TEDS)
6Methamphetamine Use in
Indiana’s Treatment
Population
Since 2010, the rate of methamphetamine
use increased significantly in all three den-
sity categories. Rates of methamphetamine
use in Indiana rise with increasing levels of
rurality and Indiana’s rural counties have
consistently had the highest rate of use
compared to both rural/mixed and urban
counties (see Figure 5).
Prescription Opioid
Analgesic1 Use in Indiana’s
Treatment Population
Indiana has experienced a significant
increase in misuse of prescription opioid
analgesics since 2010, although a slight
drop in use was noted between 2015 and
2016. The state’s urban, rural/mixed, and
rural counties have all seen a significant
increase in nonmedical opioid analgesic
use since 2010. Over time, the rate of
 opioid analgesic misuse has become
 significantly less prevalent in urban areas
compared to Indiana’s more rural counties.
In 2016, the misuse of opioid analgesics by
Hoosiers living in rural/mixed areas was
significantly higher than that found in
either urban or rural areas (see Figure 6).
Figure 5. Rate of Methamphetamine Use in Indiana’s Treatment Population, by Urban-Rural Categories
Source: Treatment Episode Data Set (TEDS)
Figure 6. Rate of Opioid Analgesic Use in Indiana’s Treatment Population, by Urban-Rural Categories
Source: Treatment Episode Data Set (TEDS)
1Opioid analgesics were defined as substances falling into the TEDS categories of “nonprescription methadone” and “other opiates and synthetics” (excluding heroin).
7Heroin Use in Indiana’s
Treatment Population
Heroin use has grown dramatically in
recent years due in large part to the
increased misuse of opioid analgesics.
Unlike in previous decades when heroin
use was typically confined to urban areas,
today, use is more prevalent in many
suburban and rural areas across the
country [14].
Since 2010, the use of heroin has increased
significantly across Indiana and within all
three population density categories. Until
2014, the rate of heroin use was highest in
urban counties with the lowest rate of use
found in rural counties. By 2016, counties
with a rural/mixed population density were
estimated to have the highest rate of hero-
in use while urban and rural counties had
rates that were similar to one another (see
Figure 7).
Prescription Drug2 Use in
Indiana’s Treatment
Population
The rate of prescription drug misuse has
risen steadily since 2010. Among urban
and rural counties, use increased from
2010 through 2015; in 2016, use declined
significantly in urban counties and
insignificantly in rural/mixed and rural
counties. Rates for 2010 show that the rate
of prescription drug misuse was approxi-
mately the same in all three density cate-
gories. By 2016, the highest rate of pre-
scription drug misuse was noted in
rural/mixed counties and the lowest in
urban counties (see Figure 8). 
Figure 7. Rate of Heroin Use in Indiana’s Treatment Population, by Urban-Rural Categories
Source: Treatment Episode Data Set (TEDS)
Figure 8. Rate of Prescription Drug Use in Indiana’s Treatment Population, by Urban-Rural Categories
Source: Treatment Episode Data Set (TEDS)
2Prescription drugs were defined as nonprescription methadone, other opiates and synthetics, sedatives, barbiturates, tranquilizers, and other amphetamines (excluding
methamphetamine)
8Injection Drug Use in
Indiana’s Treatment
Population
We also examined the distribution of injec-
tion drug use (IDU) across the three urban-
rural groups as IDU is a common way to
administer heroin and methamphetamine,
and in some instances, prescription opioids.
Injection drug users frequently share nee-
dles and other injection paraphernalia,
which puts them at a high risk for contract-
ing and transmitting infectious diseases
such as HIV or hepatitis C. As prescription
opioid, heroin, and methamphetamine use
has increased in the state, so too has the
use of needles to administer these drugs.
All population density categories had a sig-
nificant increase in IDU since 2010. As of
2016, the IDU rate was lowest among
urban dwellers, higher among rural
Hoosiers, and highest among Hoosiers liv-
ing in rural/mixed areas (see Figure 9). 
Substance Abuse
Treatment Services
In order for individuals who engage in the
misuse of substances and those with a
substance use disorder to improve, they
often need to receive some form of profes-
sional treatment. Treatment is most often
provided by state- or privately-funded
inpatient and outpatient substance-abuse-
specific agencies and also by psychiatrists,
psychologists, social workers, mental
health therapists, and addiction counselors
who may work in private practice settings.
Medication-assisted recovery services,
which are designed to help those depend-
ent on opioids, are provided by federally-
certified opioid treatment programs or fed-
erally-certified physicians. Despite the
need many people have for some form of
substance abuse treatment, most do not
receive it [2]. 
Figure 9. Rate of Injection Drug Use in Indiana’s Treatment Population, by Urban-Rural Categories
Source: Treatment Episode Data Set (TEDS)
Table 4. Substance Use Treatment Services within Urban, Rural/Mixed, and Rural Locations
Source: National Survey of Substance Abuse Treatment Services (N-SSATS), 2015
Service UrbanLocations (%)
Rural/Mixed
Locations (%)
Rural
Locations (%) Total
Detoxification (all types) 32 (56.1%) 22 (38.6%) 3 (5.3%) 57
Opioid Detoxification 27 (62.8) 15 (34.9%) 1 (2.3%) 43
Alcohol Detoxification 23 (59.0%) 15 (38.5%) 1 (2.6%) 39
Benzodiazepine Detox. 22 (57.9%) 15 (39.5%) 1 (2.6%) 38
Cocaine Detoxification 18 (62.1%) 10 (34.5%) 1 (3.4%) 29
Methamphetamine Detox. 18 (60.0%) 11 (36.7%) 1 (3.3%) 30
Methadone Treatment 7 (63.6%) 4 (36.4%) 0 (0.0%) 11
Buprenorphine 29 (60.4%) 17 (35.4%) 2 (4.2%) 48
Vivitrol 32 (49.2%) 27 (41.5%) 6 (9.2%) 65
Outpatient Treatment (all forms) 108 (52.9%) 55 (27.0%) 41 (20.1%) 204
Computerized Treatment 15 (44.1%) 14 (41.2%) 5 (14.7%) 34
Hospital Inpatient Treatment 10 (62.5%) 6 (37.5%) 0 (0.0%) 16
Long-Term Residential 19 (82.6%) 4 (17.4%) 0 (0.0%) 23
Short-Term Residential 23 (76.7%) 6 (20.0%) 1 (3.3%) 30
Programming for Specific Populations 98 (59.0%) 45 (27.1%) 23 (13.9%) 166
9Residents of rural areas who desire treat-
ment are at a particular disadvantage
compared to rural/mixed or urban loca-
tions as most services are concentrated
in more densely populated areas, making
them harder to access [15]. Rural resi-
dents may encounter other barriers to
receiving substance abuse treatment,
including stigma, fear that they may know their treatment providers, a
lack of access to specialized services, inferior quality of care, and having
to pay more for treatment [15-20].
Location of Substance Abuse Treatment
Services
We used data from the Indiana National Survey of Substance Abuse
Treatment Services (N-SSATS) to determine the address of agencies
that offer substance abuse treatment services to people in their local
area. Based on these data, Indiana, like many other states in the nation,
is lacking in substance abuse treatment services; however, rural areas of
the state are particularly underserved. Of the 235 agencies offering care,
less than one-fifth (17.8%) are located in rural areas; 11 rural counties
have no substance abuse treatment agencies whatsoever. Access to
services improves as population density increases, with 64 agencies
(27.2%) operating in rural/mixed and 129 agencies (54.9%) in urban
counties. Specialized services, such as detoxification, inpatient treat-
ment, residential programming, and programming designed for specific
populations (e.g., LGBT, veterans), are more frequently found in urban
areas. The services most easily accessible to rural Hoosiers are generally
limited to outpatient counseling. Table 4 provides a breakdown of the
number and percent of agencies offering different types of services in
the three urban-rural categories.
Location of Buprenorphine Prescribers and
Opioid Treatment Programs (OTP)
Buprenorphine is a relatively new treatment for people with opioid use
disorders. Buprenorphine works by suppressing the symptoms associ-
ated with opioid withdrawal and consequently reducing cravings and
use of opioids [21]. Only specially certified physicians can prescribe
Buprenorphine. Physicians can either have a caseload limit of 30, 100,
or 275 patients. Using the Buprenorphine physician locator available
from SAMHSA, we determined that as of April 2017, 337 physicians in
the state are authorized to prescribe Buprenorphine, although the
 number of physicians who can see 30, 100, or 275 patients was not
available. Overall, half of Indiana’s counties currently have no
Buprenorphine prescriber and the majority of those counties (80.4%)
are considered rural. When we counted the number of physicians with-
in each urban-rural category, we determined that 76.3% of physicians
were in urban, 22.0% in rural/mixed, and only 1.8% in rural areas. The
distribution of physicians who are able to prescribe Buprenorphine in
Indiana is similar to that seen throughout the country [22]. 
Methadone is another drug commonly used to treat opioid disorders.
Methadone works by lessening the painful symptoms of opiate with-
drawal, blocks the euphoric effects of opiate drugs, and reduces the
chances an individual will return to opioid use. Methadone is dispensed
at specifically designated opioid treatment programs (OTP) [23].
Significant research shows that methadone is an effective treatment for
reducing the use of opioids, IDU, and the spread of HIV, HCV, and
other blood-borne illnesses [24]. There are currently 14 OTPs operating
in Indiana; 13 of which are overseen by the Division of Mental Health
and Addiction and one OTP is administered by the Veteran’s
Administration [25]. Of these 14 OTPs, 10 are located in urban areas
and four are in rural/mixed areas; no OTPs are located in rural counties. 
Location of the Substance Use Treatment
Workforce
The availability of substance use services is dependent on having an
easily accessible pool of trained substance use treatment professionals.
Using data available from the National Provider Identifier (NPI)
dataset, we determined that there are approximately 5,668 professionals
with an active NPI number who are licensed as social workers, mental
health therapists, addictions counselors, or psychologists, all of whom
could potentially provide some form of substance abuse treatment serv-
ices to individuals within their communities. As with other services,
treatment professionals are more often found in areas that have greater
population densities (see Table 5). 
Table 5. Substance Use Treatment Workforce by Provider Type Located in Urban, Rural/Mixed, and Rural Areas
Source: National Provider Identifier (NPI) dataset
Provider Type3 Total Number Urban Rural/Mixed Rural
Masters-Level Provider 4,814 3,574 (74.2%) 988 (20.5%) 252 (5.2%)
Doctoral-Level Provider 854 662 (77.5%) 157 (18.4%) 35 (4.1%)
Psychiatrist 585 436 (74.5%) 142 (24.3%) 7 (1.2%)
3Masters-level providers are licensed social workers, mental health therapists, marital and family therapists, and addiction counselors. Doctoral-level providers are licensed
psychologists holding either a PhD or PsyD degree. Psychiatrists are physicians (MDs or DOs) specializing in the practice of psychiatry.
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Psychiatrists are another important piece of the substance use treat-
ment workforce. The NPI database reports that 585 psychiatrists are
located in Indiana. Three-quarters of the state’s psychiatrists have prac-
tices in urban areas, with the remainder primarily serving rural/mixed
areas (24.3%) and only seven psychiatrists (1.2%) serving rural areas of
Indiana. Of Indiana’s 92 counties, 47 do not have a psychiatrist and of
those counties, 36 are rural (see Table 5). 
Thoughts for Policymakers
The state has seen a shift in substance use rates over time, with
rural/mixed and rural areas experiencing an increase and urban areas a
decrease in use. Presently, the overall rate of substance use in urban
areas is generally lower than that found in less population-dense coun-
ties. Furthermore, there are some clear differences in the rate that cer-
tain substances are being used, particularly evident for methampheta-
mine use (primarily rural and rural/mixed counties) and cocaine use
(primarily urban counties). Based on these findings, we would make the
following recommendations to address substance use across the state.
Target rural/mixed and rural areas for
expansion of substance abuse treatment
services that can address all levels of sub-
stance abuse issues.
The N-SSATS data clearly show that residents of less densely populat-
ed areas have less access to all forms of substance abuse treatment [26].
Although high rates of use in more rural counties may translate to a
smaller number of affected individuals, this should not dissuade the
state from at minimum increasing the availability of specialty substance
abuse treatment services in these areas. These services include, but are
not limited to: detoxification services, especially those for opioids, alco-
hol, and methamphetamine; inpatient services; and short- and long-
term residential services. It is also important to ensure that services are
evidence-based and of equal quality to those found in urban counties.
Increase the availability of Medication-
Assisted Treatment services, particularly in
rural/mixed areas, to reduce continued mis-
use of prescription opioids and heroin.
Despite the higher rate of opioid use in Indiana’s rural/mixed and rural
areas, few if any OTPs operate in those locations [27]. Should Indiana
decide to increase OTP capacity, consideration should be given to
locating new facilities in areas accessible to Hoosiers in moderately or
completely rural areas where the treatment need is high and availabili-
ty is practically nonexistent. The state could also seek approval from
SAMHSA to provide methadone maintenance through mobile clinics
that travel to and provide daily services in areas of high need, an
approach that has been shown to be effective in serving hard-to-reach
individuals who are dependent on opioids [28].
As an alternative to increasing capacity for methadone treatment,
Indiana could focus on improving access to Buprenorphine, since it can
be prescribed in a physician’s office. The first step to enhance
Buprenorphine availability would be to increase the number of waivered
physicians in rural/mixed and rural areas. This task could be challenging
as non-waivered physicians in other states report not wanting to get
waivers for fear they will be flooded with requests for Buprenorphine or
that patients will divert the drug [29]. The second step would be to
encourage physicians with waivers to actually prescribe Buprenorphine
and to prescribe it to the full number of patients for whom they are
authorized. Waivered physicians in other states often avoid prescribing,
or they keep their patient loads below their assigned limit due to insuffi-
cient reimbursement, lack of time for taking on additional patients, and
concerns surrounding the use of Buprenorphine [29].
For Indiana to accomplish this, the state may need to cover the costs
associated with obtaining the waiver and establish training and men-
toring programs to provide physicians with a better understanding of
opioid use disorders, how to effectively use Buprenorphine with
patients that have them, and how to manage larger caseloads—activi-
ties which other states have successfully implemented to increase
Buprenorphine prescribing rates [30-32]. As of 2016, nurse practitioners
and physicians assistants can also apply for Buprenorphine waivers
[33]. Indiana may want to target these lower-level providers with simi-
lar programming and support in order to maximize the number of
waivered professionals not only in moderately and fully rural areas but
across the whole of Indiana. 
Increase distribution and use of Naloxone in
rural/mixed and rural areas in order to com-
bat high ED use and overdose deaths among
those who misuse prescription opioids or
heroin.
As seen in other states [34-36], Indiana’s opioid overdoses and over-
dose-related deaths occur with greater frequency in less densely popu-
lated areas of the state. Similarly, rates of emergency department visits
related to opioid use are higher in counties that are of a rural/mixed
composition. In states with similar patterns of overdoses, rural resi-
dents dependent on opioids were found to be less aware of what
behaviors could put them at risk for overdose [34], and such a situation
may exist locally. 
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Lacking easy access to Naloxone, a medication that can reverse the
symptoms of an opioid overdose, may also help explain the higher
rates of overdoses and emergency department use in rural/mixed areas.
Although first responders such as police officers, firefighters, and emer-
gency medical technicians typically carry Naloxone, in more rural com-
munities critical time may be lost between alerting helping profession-
als of an overdose and these professionals arriving at the scene. To
avoid such delays, the Indiana legislature passed legislation that allows
all Hoosiers to legally obtain Naloxone without a prescription and
administer it to someone who is having an overdose. However, in
more rural areas, sources of Naloxone and training on how and when
to properly use it are scarcer than in urban parts of the state. 
Indiana could consider allowing Naloxone to be dispensed through a
wider range of settings such as social service agencies, local schools,
and faith-based organizations. These types of organizations often have
contact with a large percentage of their local population, making them
ideal locations for both distribution of and education on Naloxone, as
well as the risk factors associated with overdose.
Enhance Indiana’s capacity to provide inter-
net-based services to Hoosiers struggling
with methamphetamine use in more remote
areas of the state.
As noted previously, the rate of methamphetamine use and metham-
phetamine use disorders are higher in more rural areas and particularly
so in Indiana’s most rural counties. Additionally, problematic alcohol
and marijuana use are higher in areas of lower population density.
Residents of these counties who desire help for their substance use
issues have little if any access to agencies or professionals that can pro-
vide some form of treatment. To reach citizens living in more remote
counties who either cannot access treatment or who might feel stigma-
tized by doing so, the state could capitalize on internet technology.
Community mental health centers located near counties with few serv-
ices could designate therapists to conduct some or all treatment ses-
sions via internet applications that allow for face-to-face communica-
tion, many of which can be used on a desktop computer, a laptop, a
tablet, or a smart phone. Additionally, community mental health cen-
ters can make use of internet-accessible, computerized treatment pro-
tocols to supplement face-to-face sessions. Internet and computer-
based forms of intervention have been used successfully with individu-
als facing substance use or other mental health concerns, and outcomes
are equal to or sometimes better than traditional in-person approaches
[37-42].
Provide Training and Mentoring to Primary
Care Physicians and other Healthcare
Professionals on how to Identify Substance
Abuse in Patients and Provide Treatment.
In many rural areas of Indiana, primary care providers (PCP) may be
the only easily accessible source of treatment for someone experiencing
problematic substance use. It may benefit the state to invest in training
and mentoring programs that can help to improve primary care profes-
sionals’ knowledge about and comfort level with caring for these
patients. The Extension for Community Healthcare Outcomes (ECHO)
is one successful approach for both enhancing primary care providers’
knowledge of and relieving their anxiety about caring for patients with
complex health conditions, such as substance abuse [30]. ECHO is an
educational approach where specialists at a centrally located agency use
video technology to connect to PCPs throughout a community. ECHO
emphasizes case-based learning that allows for discussion of treatment
approaches and serves as a way for specialists to share their expertise
while also mentoring PCPs in their efforts to offer high-quality, special-
ized care to their patients. ECHO has been used to enhance PCPs’ abil-
ity to treat various health conditions, including some forms of sub-
stance use disorders, and at minimum may allow for more individuals
with substance use disorders to be identified and directed to whatever
treatment services are locally available [30, 32]. 
Incentivize treatment professionals to work
in more rural areas of Indiana.
Finally, Indiana might consider incentivizing substance abuse treatment
professionals to establish practices outside of the state’s urban centers.
On a national level the National Health Service Corps offers loan
repayment to primary care providers, including mental and behavioral
health workers, who choose to practice in healthcare shortage areas for
a given period of time. Unfortunately, repayment funds are limited and
applications from physicians are often given preference over mental
and behavioral health care providers [43]. The Indiana Division of
Mental Health and Addictions also offers a loan repayment program
for licensed addictions professionals willing to work in designated,
underserved parts of the state including more rural communities [44].
To increase the number of such workers in rural/mixed and rural areas,
Indiana may need to more aggressively market the loan repayment
program, alter the requirements, offer repayment to individuals who
paid for their education out-of-pocket, or increase the funds for the
program to ensure that lower-level providers are as likely as physician-
level providers to receive reimbursement.
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Appendix 2 – Data Sources
U.S. Census Bureau – Community Fact Finder (CFF)
Data on demographic, economic, and employment variables were
gathered from the CFF and aggregated by population density category
(urban, rural/mixed, and rural). The census generally pools estimates
for the CFF across a five-year period to ensure that all counties are rep-
resented. We used data which pooled estimates from 2011-2015 when-
ever possible.
Treatment Episode Data Set – Admissions (TEDS)
Currently, little data are available to estimate prevalence rates of sub-
stance use at the county level. For this reason, we relied primarily on
TEDS data, which is produced annually by Indiana’s Division of Mental
Health and Addiction and then submitted to SAMHSA. TEDS collects
data on admissions to substance abuse treatment for Hoosiers who are
at or below the 200% federal poverty level and who receive these serv-
ices through publicly funded treatment sources [45]. For the analyses,
we examined seven years of data, from 2010 to 2016, in order to pres-
ent trends in substance use and associated disorders over time as well
as to highlight urban/rural population differences for 2016. 
The use of the TEDS data presents some limitations. Since TEDS only
covers a specific population, it is difficult to determine how representa-
tive these findings are of the general population. It is possible that the
estimates presented are underestimates of the actual prevalence of both
problematic use and substance use disorders due to the fact that only
individuals experiencing significant consequences from substance use
chose or were court-ordered to enter treatment. Given that individuals
represented in TEDS likely have a pattern of use that varies in some
way from that of Indiana’s general population, the findings presented
below should be interpreted with caution. 
National Survey of Substance Abuse Treatment 
Services (N-SSATS) 
To determine the level of treatment services available in the state and
where these services are located, we relied on the N-SSATS. SAMHSA
conducts the N-SSATS on an annual basis in order to collect informa-
tion on all organizations that provide substance abuse treatment servic-
es through the use of federal dollars. The survey includes questions
covering the programs’ location, the nature of the services offered, and
a rough estimate of the number of clients receiving services.
Correctional facilities and professionals in private practice are not
included in the N-SSATS [26]. 
Buprenorphine Provider Database
To determine the number and location of physicians who are authorized
to prescribe buprenorphine as part of a medication-assisted treatment
program, we used SAMHSA’s buprenorphine physician locator data-
base. This resource provides a relatively comprehensive list of approved
prescribers within each state. The database does not indicate whether a
physician is authorized to prescribe to 30, 100, or 275 patients.
Furthermore, physicians can choose not to be listed in the database. 
National Provider Identifier (NPI) Dataset 
To determine where individual-level substance abuse service providers
(i.e., psychiatrists, psychologists, counselors, and social workers) were
located in the state, we used the NPI data set, which is compiled by the
Center for Medicare and Medicaid Services (CMS). The NPI contains
provider information for healthcare professionals who accept Medicare
and Medicaid. CMS updates this database on a periodic basis; however,
it is up to individual providers to alert CMS regarding address changes.
The NPI likely underestimates to some extent the number of service
providers, as not all service providers accept Medicare or Medicaid for
reimbursement. 
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Appendix 3 –Substance Use in Indiana’s Treatment Population, Percentages and Rates by
Urban/Rural Category (TEDS, 2016) 
Urban Rural/Mixed Rural Indiana
Alcohol
Percent of Admissions 51.1%a 49.0%b 51.2%a 50.0%
Rate per 1,000 population >= 18 3.03*† 3.39 3.51 3.19
Marijuana
Percent of Admissions 45.6%a 48.7%b 48.9%b 47.0%
Rate per 1,000 population >= 18 2.71*† 3.37 3.35 2.98
Cocaine
Percent of Admissions 14.4%a 7.3%b 5.2%c 11.0%
Rate per 1,000 population >= 18 0.85*†  0.51‡ 0.35 0.69
Heroin
Percent of Admissions  19.9%a 19.3%a 16.5%b 19.0%
Rate per 1,000 population >= 18 1.18* 1.33‡ 1.13 1.21
Methamphetamine
Percent of Admissions 13.8%a 27.0%b 30.7%c 20.0%
Rate per 1,000 population >= 18 0.82*† 1.87‡ 2.10 1.29
Prescription Opioids
Percent of Admissions 20.8%a 27.3%b 24.3%c 23.0%
Rate per 1,000 population >= 18 1.23*† 1.89‡ 1.66 1.47
All Prescription Medications (including Opioids)
Percent of Admissions 26.4%a 33.4%b 30.4%c 29.0%
Rate per 1,000 population >= 18 1.56*† 2.31‡ 2.08 1.84
Injection Drug Use
Percent of Admissions 18.9%a 22.6%b 18.5%a 20.0%
Rate per 1000 population>=18 1.12*† 1.57‡ 1.27 1.26
Urban Rural/Mixed Rural Indiana
Alcohol
Percent of Admissions 34.6%a 31.2%b 31.6%b 33.0%
Rate per 1,000 population >= 18 2.05* 2.16 2.16 2.09
Marijuana
Percent of Admissions 20.5%a 17.2%b 18.0%b 19.0%
Rate per 1,000 population >= 18 1.21 1.19 1.23 1.21
Cocaine
Percent of Admissions 5.3%a 1.5%b 0.8%c 4.0%
Rate per 1,000 population >= 18 0.32*† 0.10‡ 0.06 0.22
Heroin
Percent of Admissions 16.2%a 13.7%b 12.1%c 15.0%
Rate per 1,000 population >= 18 0.96† 0.95‡ 0.83 0.94
Methamphetamine
Percent of Admissions 7.3%a 15.3%b 16.1%b 11.0%
Rate per 1,000 population >= 18 0.43*† 1.06‡ 1.10 0.70
Prescription Opioids
Percent of Admissions 11.9%a 14.0%b 10.6%c 12.0%
Rate per 1,000 population >= 18 0.71* 0.97‡ 0.73 0.78
All Prescription Medications (including Opioids)
Percent of Admissions 13.7%a 16.3%b 12.8%a 14.0%
Rate per 1,000 population >= 18 0.81* 1.13‡ 0.87 0.91
Any Use of Substance
Primary Use of Substance
a, b, c – columns with different letters represent significant (P<.05) differences between those columns (e.g., a column with a and a column with b are significantly different
from one another)
*—urban significantly different (P<.05) from rural/mixed
†—urban significantly different (P<.05) from rural
‡—rural/mixed significantly different (P<.05) from rural
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Appendix 4 – Substance Use Trends
Rates (per 1.000 Population) and General Trends in Indiana’s Substance Abuse Treatment Admissions Reporting Any Use of Specific
Drugs across Urban-Rural Categories over Time (TEDS, 2010 – 2016)
Trend 2010 2011 2012 2013 2014 2015 2016
Overall Substance Use
Indiana 5.71 6.25 6.46 6.46 6.53 6.58 6.33
Urban 6.17 6.38 6.42 6.35 6.33 6.38 5.93
Rural/Mixed 4.81 5.79 6.39 6.49 6.70 6.81 6.92
Rural 5.58 6.60 6.76 6.83 7.06 6.98 6.85
Alcohol Any Use
Indiana 3.92 4.08 3.93 3.82 3.69 3.50 3.20
Urban 4.25 4.15 2.97 3.81 3.63 3.41 3.03
Rural/Mixed 3.20 3.71 3.69 3.62 3.58 3.56 3.39
Rural 3.96 4.53 4.28 4.21 4.11 3.81 3.51
Alcohol Primary Drug
Indiana 2.70 2.77 2.73 2.64 2.52 2.36 2.09
Urban 2.86 2.76 2.76 2.66 2.51 2.36 2.05
Rural/Mixed 2.28 2.61 2.55 2.49 2.42 2.32 2.16
Rural 2.82 3.13 2.93 2.88 2.71 2.41 2.16
Marijuana Any Use
Indiana 2.95 3.16 3.05 3.01 3.01 3.08 2.98
Urban 3.22 3.25 3.05 2.96 2.90 2.91 2.71
Rural/Mixed 2.39 2.88 2.95 3.00 3.08 3.28 3.37
Rural 2.91 3.36 3.29 3.21 3.38 3.39 3.35
Marijuana Primary Drug
Indiana 1.25 1.39 1.26 1.22 1.25 1.25 1.21
Urban 1.42 1.53 1.33 1.30 1.32 1.32 1.21
Rural/Mixed 0.92 1.08 1.11 1.10 1.12 1.14 1.19
Rural 1.19 1.38 1.28 1.15 1.20 1.17 1.23
Cocaine Any Use
Indiana 1.00 1.00 1.01 0.87 0.77 0.73 0.69
Urban 1.37 1.30 1.29 1.09 0.97 0.91 0.85
Rural/Mixed 0.50 0.62 0.82 0.64 0.52 0.52 0.51
Rural 0.40 0.52 0.50 0.43 0.39 0.36 0.35
Cocaine Primary Drug
Indiana 0.40 0.38 0.43 0.32 0.26 0.24 0.22
Urban 0.58 0.55 0.56 0.44 0.38 0.34 0.32
Rural/Mixed 0.15 0.16 0.30 0.20 0.11 0.10 0.10
Rural 0.11 0.14 0.16 0.10 0.06 0.04 0.06
Heroin Any Use
Indiana 0.34 0.46 0.61 0.69 0.83 1.07 1.21
Urban 0.46 0.56 0.67 0.76 0.88 1.10 1.18
Rural/Mixed 0.21 0.34 0.57 0.65 0.80 1.07 1.33
Rural 0.14 0.29 0.42 0.51 0.68 0.93 1.13
(continued on next page)
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Appendix 4 – (continued from previous page)
Trend 2010 2011 2012 2013 2014 2015 2016
Heroin Primary Drug
Indiana 0.28 0.35 0.44 0.52 0.63 0.82 0.94
Urban 0.38 0.46 0.53 0.61 0.71 0.91 0.96
Rural/Mixed 0.14 0.21 0.33 0.42 0.54 0.72 0.95
Rural 0.10 0.18 0.25 0.32 0.45 0.62 0.83
Meth. Any Use
Indiana 0.62 0.72 0.76 0.81 0.96 1.09 1.29
Urban 0.42 0.45 0.49 0.52 0.60 0.69 0.82
Rural/Mixed 0.79 0.97 1.03 1.15 1.34 1.57 1.87
Rural 1.11 1.33 1.38 1.38 1.69 1.84 2.10
Meth. Primary Drug
Indiana 0.34 0.40 0.43 0.48 0.59 0.66 0.70
Urban 0.22 0.24 0.27 0.28 0.33 0.38 0.43
Rural/Mixed 0.48 0.58 0.61 0.75 0.91 1.03 1.06
Rural 0.58 0.72 0.71 0.79 1.02 1.08 1.10
Pain Relievers Any Use
Indiana 0.88 1.13 1.36 1.50 1.56 1.57 1.47
Urban 0.87 1.05 1.20 1.32 1.34 1.35 1.23
Rural/Mixed 0.94 1.30 1.63 1.80 1.88 1.89 1.89
Rural 0.82 1.14 1.49 1.71 1.84 1.84 1.66
Pain Relievers Primary Drug
Indiana 0.51 0.66 0.81 0.88 0.89 0.86 0.78
Urban 0.51 0.61 0.72 0.81 0.81 0.80 0.71
Rural/Mixed 0.56 0.77 0.97 0.99 1.02 0.94 0.97
Rural 0.44 0.62 0.87 0.96 1.01 0.95 0.73
Rx Medication Any Use
Indiana 1.20 1.53 1.83 1.90 1.90 1.93 1.84
Urban 1.18 1.41 1.58 1.64 1.65 1.69 1.56
Rural/Mixed 1.24 1.74 2.25 2.31 2.27 2.30 2.31
Rural 1.20 1.60 2.01 2.15 2.24 2.25 2.08
RX Medication Primary Drug
Indiana 0.63 0.82 1.01 1.07 1.06 1.01 0.91
Urban 0.61 0.74 0.86 0.94 0.93 0.92 0.81
Rural/Mixed 0.69 0.98 1.28 1.28 1.25 1.14 1.13
Rural 0.59 0.79 1.07 1.19 1.24 1.14 0.87
Injection Drug Use
Indiana 0.42 0.55 0.66 0.78 0.96 1.17 1.26
Urban 0.45 0.57 0.66 0.75 0.90 1.07 1.12
Rural/Mixed 0.41 0.54 0.70 0.86 1.09 1.36 1.57
Rural 0.29 0.48 0.62 0.76 0.97 1.19 1.27
Note: = increasing trend; = decreasing trend; = increasing followed by decreasing trend; = relatively stable trend; = increasing trend followed by
 stability;  = decreasing trend followed by stability
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